Universal Sequencing Technology (UST) was established by a group of NGS technology veterans. UST is dedicated to the development of the most advanced, cost-effective, long-read, DNA sequencing technologies. By 2017 UST had received a total initial seed investment of $6MM and had filed patents on two key technologies. In June of 2018 UST successfully raised an additional $8MM from strategic partner, Amoy Diagnostics Co., Ltd.
Currently, Universal Sequencing Technology has filed a total of 14 patent applications covering linked, long-read library preparation chemistry and groundbreaking 3rd generation DNA sequencing technology.
Universal Sequencing will lead the next wave of DNA sequencing innovations.